PT1596868E - Método para o tratamento de insuficiência cardíaca grave e medicamento associado - Google Patents

Método para o tratamento de insuficiência cardíaca grave e medicamento associado Download PDF

Info

Publication number
PT1596868E
PT1596868E PT04713672T PT04713672T PT1596868E PT 1596868 E PT1596868 E PT 1596868E PT 04713672 T PT04713672 T PT 04713672T PT 04713672 T PT04713672 T PT 04713672T PT 1596868 E PT1596868 E PT 1596868E
Authority
PT
Portugal
Prior art keywords
heart failure
severe heart
treating severe
medicament therefor
medicament
Prior art date
Application number
PT04713672T
Other languages
English (en)
Portuguese (pt)
Inventor
Atsushi Ozaki
Yosuke Maki
Osamu Sato
Yoshitaka Yamamura
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32908667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1596868(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of PT1596868E publication Critical patent/PT1596868E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT04713672T 2003-02-24 2004-02-23 Método para o tratamento de insuficiência cardíaca grave e medicamento associado PT1596868E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44887803P 2003-02-24 2003-02-24

Publications (1)

Publication Number Publication Date
PT1596868E true PT1596868E (pt) 2009-01-14

Family

ID=32908667

Family Applications (1)

Application Number Title Priority Date Filing Date
PT04713672T PT1596868E (pt) 2003-02-24 2004-02-23 Método para o tratamento de insuficiência cardíaca grave e medicamento associado

Country Status (23)

Country Link
US (2) US7423032B2 (https=)
EP (2) EP2000142A1 (https=)
JP (2) JP4771937B2 (https=)
KR (1) KR100706727B1 (https=)
CN (1) CN100577171C (https=)
AR (1) AR043259A1 (https=)
AT (1) ATE411803T1 (https=)
AU (2) AU2004212842B9 (https=)
BR (1) BRPI0405657A (https=)
CA (1) CA2493475A1 (https=)
CY (1) CY1108583T1 (https=)
DE (1) DE602004017283D1 (https=)
DK (1) DK1596868T3 (https=)
ES (1) ES2315640T3 (https=)
MX (1) MXPA05001623A (https=)
MY (1) MY143740A (https=)
NO (1) NO335369B1 (https=)
PL (2) PL404315A1 (https=)
PT (1) PT1596868E (https=)
RU (2) RU2346689C2 (https=)
SI (1) SI1596868T1 (https=)
TW (1) TWI322689B (https=)
WO (1) WO2004073716A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7468390B2 (en) * 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
TWI322689B (en) * 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
DK1968990T3 (da) 2005-12-27 2015-04-27 Otsuka Pharma Co Ltd Vandopløselig benzoazepinforbindelse og farmaceutisk sammensætning deraf
JP5076327B2 (ja) * 2006-02-01 2012-11-21 味の素株式会社 分岐鎖アミノ酸の心不全適応
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
PT2146721E (pt) * 2007-05-15 2013-07-18 Otsuka Pharma Co Ltd Métodos de utilização de antagonistas da vasopressina com agentes quimioterapeuticos de antraciclina para reduzir a cardiotoxicidade e/ou melhorar a sobrevivência
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
WO2011104269A1 (en) 2008-02-26 2011-09-01 Jenavalve Technology Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US10856978B2 (en) 2010-05-20 2020-12-08 Jenavalve Technology, Inc. Catheter system
CN103002833B (zh) 2010-05-25 2016-05-11 耶拿阀门科技公司 人工心脏瓣及包括人工心脏瓣和支架的经导管输送的内假体
JP5477413B2 (ja) * 2012-04-24 2014-04-23 味の素株式会社 分岐鎖アミノ酸の心不全適応
WO2015028209A1 (en) 2013-08-30 2015-03-05 Jenavalve Technology Gmbh Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
WO2016150806A1 (en) 2015-03-20 2016-09-29 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath
CN107530168B (zh) 2015-05-01 2020-06-09 耶拿阀门科技股份有限公司 在心脏瓣膜替换中具有降低的起搏器比例的装置和方法
CN109475419B (zh) 2016-05-13 2021-11-09 耶拿阀门科技股份有限公司 用于通过引导鞘和装载系统来递送心脏瓣膜假体的心脏瓣膜假体递送系统和方法
CN110392557A (zh) 2017-01-27 2019-10-29 耶拿阀门科技股份有限公司 心脏瓣膜模拟
CN110174474B (zh) * 2019-05-24 2022-02-18 石家庄四药有限公司 复方电解质注射液(ⅱ)中l-苹果酸异构体的检测方法
CN112121051B (zh) * 2020-09-30 2021-06-18 郑州大学 莫扎伐坦在制备抗消化道肿瘤药物中的应用
CN120152682A (zh) 2022-11-09 2025-06-13 耶拿阀门科技公司 用于顺序地部署可扩张植入物的导管系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01102124A (ja) 1987-10-14 1989-04-19 Kubota Ltd コンクリート構造体支持構造
US5753677A (en) * 1989-10-20 1998-05-19 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
US5258510A (en) 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
DK0450097T3 (da) 1989-10-20 1996-05-20 Otsuka Pharma Co Ltd Benzoheterocykliske forbindelser
AU657424B2 (en) 1992-07-02 1995-03-09 Otsuka Pharmaceutical Co., Ltd. Oxytocin antagonist
JPH0680641A (ja) 1992-09-01 1994-03-22 Otsuka Pharmaceut Co Ltd 光学活性な５−ヒドロキシベンゾアゼピン誘導体の製造法
TW354762B (en) 1993-02-23 1999-03-21 Otsuka Pharma Co Ltd Agent for prophylaxis or treatment of cataract
JP2694319B2 (ja) 1993-12-24 1997-12-24 大塚製薬株式会社 抗潰瘍剤
JP3002766B2 (ja) 1994-12-09 2000-01-24 大塚製薬株式会社 脳浮腫治療剤
JPH10120592A (ja) 1996-10-22 1998-05-12 Otsuka Pharmaceut Co Ltd メニエール病乃至メニエール症候群治療剤
JP4210355B2 (ja) 1997-07-03 2009-01-14 大塚製薬株式会社 固形製剤組成物
EP1253945B1 (en) 2000-01-26 2006-10-04 Astellas Pharma Inc. Ace inhibitor-vasopressin antagonist combinations
US20030103983A1 (en) * 2002-05-09 2003-06-05 Pressler Milton Lethan Ace inhibitor-vasopressin antagonist combinations
US20030008860A1 (en) 2002-05-09 2003-01-09 Bakker-Arkema Rebecca Guggemos Treatment of congestive heart failure
ES2288899T3 (es) * 2000-10-04 2008-02-01 Astellas Pharma Inc. Uso de un antagonista de vasopresina tal como conivaptan en la fabricacion de un medicamento para el tratamiento de la hipertension pulmonar.
TWI322689B (en) * 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor

Also Published As

Publication number Publication date
EP1596868A4 (en) 2006-03-29
JP2011148806A (ja) 2011-08-04
AU2004212842B9 (en) 2009-03-05
EP1596868B1 (en) 2008-10-22
NO335369B1 (no) 2014-12-01
ATE411803T1 (de) 2008-11-15
HK1084037A1 (zh) 2006-07-21
KR20050105972A (ko) 2005-11-08
US20080214523A1 (en) 2008-09-04
AU2004212842A1 (en) 2004-09-02
NO20050569L (no) 2005-11-22
CY1108583T1 (el) 2014-04-09
PL404315A1 (pl) 2013-08-05
ES2315640T3 (es) 2009-04-01
EP2000142A1 (en) 2008-12-10
US20050187210A1 (en) 2005-08-25
AR043259A1 (es) 2005-07-20
PL218069B1 (pl) 2014-10-31
TW200418489A (en) 2004-10-01
RU2346689C2 (ru) 2009-02-20
RU2008133654A (ru) 2010-02-20
RU2005102110A (ru) 2005-09-20
KR100706727B1 (ko) 2007-04-12
EP1596868A1 (en) 2005-11-23
AU2004212842B2 (en) 2009-01-08
BRPI0405657A (pt) 2005-07-19
CA2493475A1 (en) 2004-09-02
US7749993B2 (en) 2010-07-06
SI1596868T1 (sl) 2008-12-31
JP4771937B2 (ja) 2011-09-14
MY143740A (en) 2011-07-15
JP2006518731A (ja) 2006-08-17
DE602004017283D1 (de) 2008-12-04
NO20050569D0 (no) 2005-02-02
CN100577171C (zh) 2010-01-06
AU2009201109A1 (en) 2009-04-09
DK1596868T3 (da) 2008-12-08
CN1700919A (zh) 2005-11-23
TWI322689B (en) 2010-04-01
PL373432A1 (en) 2005-08-22
MXPA05001623A (es) 2005-04-25
WO2004073716A1 (en) 2004-09-02
US7423032B2 (en) 2008-09-09

Similar Documents

Publication Publication Date Title
PL373432A1 (en) Method for treating severe heart failure and medicament therefor
EP1680166A4 (en) METHOD AND DEVICE FOR THE TREATMENT OF HEART FAILURE
GB2398810B (en) Well treatment method and system
AU2003257613A1 (en) Catheter for treating irregular heart pulse
AU2003256253A8 (en) Aerosol for medical treatment and methods
EP1640035A4 (en) HEART TREATMENT APPARATUS AND HEART TREATMENT METHOD
AU2003303198A8 (en) Method for treating amyloid disease
AU2003213771A8 (en) Method for modification of radiotherapy treatment delivery
AU2002325435A8 (en) Medication and method for treating pathological syndrome
GB0201674D0 (en) Medical treatment
AU2002367023A8 (en) Compositions and methods for treating heart failure
AU2003232044A8 (en) Composition and method for dermatological treatment
EP1500401A4 (en) DRUGS FOR THE TREATMENT OF VASCULAR DISEASES
GB0218879D0 (en) Medical treatment
AU2003291536A8 (en) Method for the diagnosis and treatment of vascular disease
AU2002365057A8 (en) Compositions and methods for treating heart failure
ZA200502307B (en) Method for treating patients with massive blood loss
GB0208897D0 (en) New method of treatment
GB0307544D0 (en) Treatment method
GB2406865B (en) Well treatment system and method
GB0213198D0 (en) Method of treatment
GB0302691D0 (en) Treatment method
EP1841443A4 (en) METHOD AND SYSTEM FOR TREATING HEART ERRORS
GB0416872D0 (en) System and method for medical treatment
AUPS020602A0 (en) Treatment for heart failure